ARID5B
AT-rich interactive domain-containing protein 5B
Also known as: ARI5B_HUMAN, FLJ21150, MRF2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14865
- Gene
- ARID5B
- Ensembl
- ENSG00000150347
- Chromosome
- 10
- Canonical length
- 1188 aa
- Protein class
- Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol
OverviewNCBI Gene
This gene encodes a member of the AT-rich interaction domain (ARID) family of DNA binding proteins. The encoded protein forms a histone H3K9Me2 demethylase complex with PHD finger protein 2 and regulates the transcription of target genes involved in adipogenesis and liver development. This gene also plays a role in cell growth and differentiation of B-lymphocyte progenitors, and single nucleotide polymorphisms in this gene are associated with acute lymphoblastic leukemia. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Sep 2011]
Canonical amino-acid sequenceUniProt
1188 residues, UniProt reviewed canonical sequence.
>Q14865|ARID5B
1 MEPNSLQWVG SPCGLHGPYI FYKAFQFHLE GKPRILSLGD FFFVRCTPKD PICIAELQLL
61 WEERTSRQLL SSSKLYFLPE DTPQGRNSDH GEDEVIAVSE KVIVKLEDLV KWVHSDFSKW
121 RCGFHAGPVK TEALGRNGQK EALLKYRQST LNSGLNFKDV LKEKADLGED EEETNVIVLS
181 YPQYCRYRSM LKRIQDKPSS ILTDQFALAL GGIAVVSRNP QILYCRDTFD HPTLIENESI
241 CDEFAPNLKG RPRKKKPCPQ RRDSFSGVKD SNNNSDGKAV AKVKCEARSA LTKPKNNHNC
301 KKVSNEEKPK VAIGEECRAD EQAFLVALYK YMKERKTPIE RIPYLGFKQI NLWTMFQAAQ
361 KLGGYETITA RRQWKHIYDE LGGNPGSTSA ATCTRRHYER LILPYERFIK GEEDKPLPPI
421 KPRKQENSSQ ENENKTKVSG TKRIKHEIPK SKKEKENAPK PQDAAEVSSE QEKEQETLIS
481 QKSIPEPLPA ADMKKKIEGY QEFSAKPLAS RVDPEKDNET DQGSNSEKVA EEAGEKGPTP
541 PLPSAPLAPE KDSALVPGAS KQPLTSPSAL VDSKQESKLC CFTESPESEP QEASFPSFPT
601 TQPPLANQNE TEDDKLPAMA DYIANCTVKV DQLGSDDIHN ALKQTPKVLV VQSFDMFKDK
661 DLTGPMNENH GLNYTPLLYS RGNPGIMSPL AKKKLLSQVS GASLSSSYPY GSPPPLISKK
721 KLIARDDLCS SLSQTHHGQS TDHMAVSRPS VIQHVQSFRS KPSEERKTIN DIFKHEKLSR
781 SDPHRCSFSK HHLNPLADSY VLKQEIQEGK DKLLEKRALP HSHMPSFLAD FYSSPHLHSL
841 YRHTEHHLHN EQTSKYPSRD MYRESENSSF PSHRHQEKLH VNYLTSLHLQ DKKSAAAEAP
901 TDDQPTDLSL PKNPHKPTGK VLGLAHSTTG PQESKGISQF QVLGSQSRDC HPKACRVSPM
961 TMSGPKKYPE SLSRSGKPHH VRLENFRKME GMVHPILHRK MSPQNIGAAR PIKRSLEDLD
1021 LVIAGKKARA VSPLDPSKEV SGKEKASEQE SEGSKAAHGG HSGGGSEGHK LPLSSPIFPG
1081 LYSGSLCNSG LNSRLPAGYS HSLQYLKNQT VLSPLMQPLA FHSLVMQRGI FTSPTNSQQL
1141 YRHLAAATPV GSSYGDLLHN SIYPLAAINP QAAFPSSQLS SVHPSTKLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARID5B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.59
- Highest tissue expression
- 84 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 84 nTPM
- adipose tissue: 47 nTPM
- blood vessel: 41 nTPM
- smooth muscle: 40 nTPM
- gallbladder: 37 nTPM
- endometrium: 37 nTPM
Single-cell type
- syncytiotrophoblasts: 1,516 nCPM
- endometrial glandular cells: 1,191 nCPM
- basal keratinocytes: 1,081 nCPM
- b-cells: 979 nCPM
- smooth muscle cells: 970 nCPM
- thymic myoid cells: 838 nCPM
Immune cell
- naive B-cell: 41 nTPM
- memory B-cell: 38 nTPM
- T-reg: 31 nTPM
- memory CD4 T-cell: 20 nTPM
- gdT-cell: 13 nTPM
- naive CD4 T-cell: 13 nTPM
Brain region
- choroid plexus: 72 nTPM
- cerebral cortex: 55 nTPM
- pons: 53 nTPM
- thalamus: 49 nTPM
- white matter: 47 nTPM
- medulla oblongata: 45 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ARID5B.
Disease | AllUniProt
Conditions ARID5B is implicated in, by any mechanism.
- Leukemia, acute lymphoblastic (ALL) MIM:613065
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.11
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.6
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adipose tissue development
- adrenal gland development
- cell development
- cellular response to leukemia inhibitory factor
- face morphogenesis
- fat cell differentiation
- fat pad development
- female gonad development
- fibroblast migration
- kidney development
- liver development
- male gonad development
- multicellular organism growth
- muscle organ morphogenesis
- negative regulation of DNA-templated transcription
- negative regulation of transcription by RNA polymerase II
- platelet-derived growth factor receptor signaling pathway
- positive regulation of DNA-binding transcription factor activity
- post-embryonic development
- regulation of transcription by RNA polymerase II
- roof of mouth development
- skeletal system morphogenesis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- ARID DNA-binding domain
- ARID DNA-binding domain superfamily
- AT-rich Interactive Domain/SWI1 Chromatin Remodeling
- ARID/BRIGHT DNA binding domain
- AT-rich interactive domain-containing protein 5B, ARID/BRIGHT DNA binding domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ARID5B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARID5B as an antibody target. Whether an autoantibody or antibody against ARID5B could matter depends on whether native ARID5B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARID5B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ARID5B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...